| Safety Assessment of T4090 Eye Drops in Ocular Hypertensive or Glaucomatous Patients. (NCT05389267) | Laboratoires Thea | 2022-07-05 |
| Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® in the Treatment of Chronic Open-Angle Glaucoma or Ocular Hypertension in Both Eyes. (NCT05401357) | Amneal Pharmaceuticals, LLC | 2022-06-29 |
| Efficacy and Safety Assessment of T4032 (Unpreserved Bimatoprost 0.01%) Versus Lumigan® 0.01% in Ocular Hypertensive or Glaucomatous Patients (NCT05397600) | Laboratoires Thea | 2022-06-22 |
| A Study to Evaluate the Effect of Latanoprostene Bunod Ophthalmic Solution 0.024% on Episcleral Venous Pressure and Outflow Facility in Participants With Ocular Hypertension (NCT04140279) | Bausch & Lomb Incorporated | 2022-05-13 |
| Evaluation of the Safety and Effectiveness of the Bimatoprost Implant System / IOL Combination in Patients With Ocular Hypertension or Mild to Moderate Open-angle Glaucoma (NCT07154797) | SpyGlass Pharma, Inc. | 2022-04-21 |
| Nanodropper Use in Primary Open-Angle Glaucoma Patients: A Non-Inferiority Trial (NCT05844384) | 59th Medical Wing | 2022-03-17 |
| A Study to Evaluate the Efficacy and Safety of OTX-TIC (Travoprost) Intracameral Implant for Patients With Open-angle Glaucoma (OAG) or Ocular Hypertension (OHT) (NCT05335122) | Ocular Therapeutix, Inc. | 2022-03-16 |
| Study of a Latanoprost Ocular Implant for Treatment of Open Angle Glaucoma or Ocular Hypertension. (NCT05333419) | PolyActiva Pty Ltd | 2022-03-04 |
| Use of Nanodropper vs. Standard Eyedropper in Patients With Glaucoma and Ocular Hypertension (NCT05277870) | University of Washington | 2022-02-28 |
| Study in Prostaglandin Associated Peri-orbitopathy Switching From Prostaglandin Monotherapy to Omidenepag Isopropyl (NCT05279716) | Santen Pharmaceutical Asia Pte. Ltd. | 2022-02-15 |
| Optimal Treatment Protocol for Selective Laser Trabeculoplasty - Repeat Trial (NCT05159960) | Vastra Gotaland Region | 2022-01-10 |
| A Therapeutic Equivalence Study in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension (NCT05022004) | Sun Pharmaceutical Industries Limited | 2021-12-20 |
| Evaluation of Nanodropper-mediated Microdrops vs. Standard Drops of 0.5% Timolol Maleate in Glaucoma Patients (NCT05181046) | Nanodropper, Inc. | 2021-11-06 |
| A Study of Efficacy and Safety of PHP-201 in Patients With Primary Open Angle Glaucoma or Ocular Hypertension (NCT04863365) | pH Pharma | 2021-11-01 |
| A Study to Determine the Safety and Tolerability of 2 Concentrations of QLS-101 (NCT04947124) | Qlaris Bio, Inc. | 2021-10-19 |
| Comparative Study of the Efficacy of Either Krytantek Ofteno PF® or Eliptic Ofteno PF® Plus Gaap Ofteno PF® for POAG or Ocular Hypertension. (NCT04702789) | Laboratorios Sophia S.A de C.V. | 2021-10-19 |
| Direct Selective Laser Trabeculoplasty in Ethnic Chinese Population The Zhuiguang Trial (NCT05043831) | BelkinVision | 2021-10-15 |
| Inflammatory Biomarkers in Ocular Surface in Primary Open Angle Glaucoma or Ocular Hypertension Under Topical Prostaglandins (NCT05039684) | Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA | 2021-10-01 |
| PSLT Compared to Prostaglandin Analogue Eye Drops (NCT05241938) | Federal University of Rio Grande do Sul | 2021-09-01 |
| Effect of Benzalkonium Chloride Preserved and Preservative-free Latanoprost Eye Drops on Conjunctival Goblet Cells (NCT04957329) | Rigshospitalet, Denmark | 2021-09-01 |
| To Compare the Efficacy and Safety of Perrigo's Product to an FDA Approved Product for the Treatment of Glaucoma or Ocular Hypertension in Both Eyes (NCT04944290) | Padagis LLC | 2021-05-28 |
| Validation of an Automatic Analysis Algorithm of the Probability of Glaucoma From Optic Disc Images (NCT04972695) | Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA | 2021-05-07 |
| Nebivolol 0.5, 1.0, or Timolol 0.5 Suspension Compared to Timolol 0.5 Solution to Treat Glaucoma/Ocular Hypertension (NCT04910100) | Betaliq, Inc. | 2021-04-15 |
| Study to Evaluate QLS-101 Compared to Timolol Maleate Eye Drops in Subjects With High Eye Pressure (Glaucoma or Ocular Hypertension). (NCT04830397) | Qlaris Bio, Inc. | 2021-03-31 |
| Performance of the Travoprost Intraocular Implant (NCT06582732) | Glaukos Corporation | 2021-03-10 |
| Safety and Efficacy Study of JV-GL1 in Patients With Open-Angle Glaucoma or Ocular Hypertension (NCT04761705) | JeniVision, Inc. | 2021-03-10 |
| Switching From the Preserved to the Preservative - Free Latanoprost - Timolol FC in Glaucoma Patients With OSD (NCT04891588) | Klinički Bolnički Centar Zagreb | 2021-03-08 |
| 18 Month Prospective Efficacy and Safety Study of Bimatoprost Intracameral Implant (DURYSTA) (NCT04647214) | Allergan | 2021-03-03 |
| Study of LL-BMT1 in Patients With Elevated Intraocular Pressure (NCT04747808) | MediPrint Ophthalmics, Inc. | 2021-01-08 |
| Multicenter Study Assessing the Efficacy and Safety of DE-126 Ophthalmic Solution 0.002% Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension (NCT04742283) | Santen Inc. | 2020-12-17 |
| Efficacy and Safety Study of Netarsudil 0.02% Ophthalmic Solution Compared to Ripasudil Hydrochloride Hydrate 0.4% Ophthalmic Solution in Japanese Subjects With Primary Open Angle Glaucoma or Ocular Hypertension (NCT04620135) | Aerie Pharmaceuticals | 2020-11-30 |
| AGN-193408 SR in the Treatment of Open-angle Glaucoma or Ocular Hypertension (NCT04499248) | AbbVie | 2020-11-16 |
| MRCT Evaluating NCX 470 vs. Latanoprost in Subjects With Open-Angle Glaucoma or Ocular Hypertension (NCT04630808) | Nicox Ophthalmics, Inc. | 2020-11-09 |
| Glaucoma Screening Using Dynamic Analysis of Computerized Pupillary Light Reflex Assessment Device (NCT04595227) | Peking University | 2020-10-30 |
| FM101 Safety, Tolerability, Efficacy Study in the Patients With Ocular Hypertension (NCT04585100) | Future Medicine | 2020-10-07 |
| Effect of Negative Pressure on Pattern Electroretinography Readings (NCT04433702) | Vance Thompson Vision | 2020-10-01 |
| MINIject Global Long-Term Follow-up Study (NCT04524416) | iSTAR Medical | 2020-08-05 |
| Intraocular Pressure in Ocular Hypertensives With Scleral Lens Wear (NCT04442464) | Mayo Clinic | 2020-07-01 |
| A Phase 3b Study Evaluating the 24-Hour Intraocular Pressure Lowering Effect of Bimatoprost SR in Patients With Open-Angle Glaucoma or Ocular Hypertension (NCT04285580) | AbbVie | 2020-06-11 |
| A Clinical Study to Evaluate the Efficacy and Safety of CKD-351 (NCT04448223) | Chong Kun Dang Pharmaceutical | 2020-06-11 |
| 24-hour Efficacy and Tolerability of the Tafluprost-timolol Fixed Association Without Preservatives in Glaucomatous or Ocular Hypertensive Patients Already Treated With Latanoprost Preserved With BAK. A Prospective, Open Study of 3 Months Duration. (NCT05299593) | Fondazione G.B. Bietti, IRCCS | 2020-06-04 |
| Phase 3 Trial of NCX 470 vs. Latanoprost in Subjects With Open-Angle Glaucoma or Ocular Hypertension (NCT04445519) | Nicox Ophthalmics, Inc. | 2020-06-01 |
| iCare® Home vs Goldmann Applanation Tonometry (NCT04911387) | St. Erik Eye Hospital | 2020-04-01 |
| Safety and IOP-Lowering Effects of WB007 (NCT04149899) | Bausch & Lomb Incorporated | 2019-11-14 |
| Study of ST266 Given by Intranasal Delivery in Glaucoma Suspect Subjects (NCT03901781) | Noveome Biotherapeutics, formerly Stemnion | 2019-10-23 |
| Efficacy and Safety Outcomes of Optometrist Performed Selective Laser Trabeculoplasty (SLT) (NCT04036214) | Northeastern State University | 2019-08-21 |
| Retinal Effects of Balance Goggles System in Glaucoma Balance Goggles System (BGS) in Patients With Glaucoma (NCT04035239) | Stanford University | 2019-07-23 |
| To Compare the Safety and Efficacy of Perrigo's Product to an FDA Approved Product for the Treatment of Glaucoma or Ocular Hypertension in Both Eyes (NCT04024072) | Padagis LLC | 2019-06-24 |
| A Comparative Study of SPARC's SDP-133 Once Daily and Lumigan in Subjects With Open Angle Glaucoma or Ocular Hypertension (NCT03927443) | Sun Pharmaceutical Industries Limited | 2019-06-10 |
| Safety and Efficacy of Ophthalmic Phentolamine Mesylate in Glaucoma (NCT03960866) | Ocuphire Pharma, Inc. | 2019-05-28 |
| Comparison of Efficacy and Ocular Surface Disease Assessment Between Monoprost and BAK-preserved Latanoprost (NCT04743622) | CHA University | 2019-04-30 |
| Long-term Safety and Efficacy Extension Trial of Bimatoprost SR (NCT03891446) | AbbVie | 2019-03-27 |
| Efficacy and Systemic Safety of Netarsudil 0.01%, 0.02%, 0.04% Relative to Placebo in Subjects With Open-angle Glaucoma or Ocular Hypertension in Japan (NCT03844945) | Aerie Pharmaceuticals | 2019-03-19 |
| Evaluation of the Duration of Effect of Bimatoprost SR in Participants With Open-Angle Glaucoma or Ocular Hypertension (NCT03850782) | AbbVie | 2019-02-28 |
| Tafluprost Preservative Free Switch Study (NCT04654611) | Tun Hussein Onn National Eye Hospital | 2019-02-01 |
| Optimal Treatment Protocol for Selective Laser Trabeculoplasty (NCT03798223) | Vastra Gotaland Region | 2019-01-10 |
| Levobetaxolol Hydrochloride Eye Drops for Treatment of Primary Open-angle Glaucoma or Ocular Hypertension (NCT02617459) | Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. | 2019-01-04 |
| Prophylaxis for Anti-VEGF-induced IOP Elevation (NCT02623023) | McMaster University | 2019-01-01 |
| Study of Rhopressa® for the Reduction of Elevated Intraocular Pressure in Patients With Glaucoma or Ocular Hypertension in a Real-world Setting (NCT03808688) | Aerie Pharmaceuticals | 2018-12-27 |
| A Clinical Study to Evaluate the Efficacy and Safety of CKD-351 (NCT03762369) | Chong Kun Dang Pharmaceutical | 2018-12-07 |
| A Study to Assess an Automated Laser Device for Direct Selective Laser Trabeculoplasty (NCT03750201) | BelkinVision | 2018-10-19 |
| Clinical Study Comparing Two Models of a Travoprost Intraocular Implant (NCT03868124) | Glaukos Corporation | 2018-09-17 |
| Evaluation of Safety and Efficacy of PDP-716 (NCT03450629) | Sun Pharma Advanced Research Company Limited | 2018-09-13 |
| Comparing Refractive and Visual Outcomes of MIGS and Traditional Surgeries (NCT03584958) | Wills Eye | 2018-08-01 |
| Randomized Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophthalmic Solution, 0.5% (NCT03519386) | Glaukos Corporation | 2018-07-26 |
| Is the Reduction in IOP After Treatment of 180 Degrees Equivalent to Treatment of 360 Degrees With SLT? (NCT03529591) | Western University, Canada | 2018-06-29 |
| Safety, Tolerability and Preliminary Efficacy of Unilateral Latanoprost-loaded Punctual Plug -EXP-LP (NCT03318146) | Shaare Zedek Medical Center | 2018-06-01 |
| The Effect of a Scleral Lens on the Anterior Chamber Depth and Minimum Rim Width (NCT03926975) | University of Houston | 2018-06-01 |
| CLN-0045: Safety, and Efficacy of OTX-TIC in Participants With Open Angle Glaucoma or Ocular Hypertension (NCT04360174) | Ocular Therapeutix, Inc. | 2018-04-25 |
| Investigation of Neurovascular Coupling in Glaucoma Patients and Healthy Subjects (NCT03870230) | Medical University of Vienna | 2017-12-01 |
| Foot Reflexology in Ocular Hypertensive and Glaucoma Patients (NCT04695314) | Temple University | 2017-11-07 |
| A Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7058584 Following 7 Days of Instillation of Eye Drops in Patients With Primary Open Angle Glaucoma or Ocular Hypertension (NCT03293992) | Hoffmann-La Roche | 2017-10-10 |
| Safety and Efficacy Study of PG324 (Netarsudil/Latanoprost 0.02% / 0.005%) Ophthalmic Solution Compared to GANFORT® Ophthalmic Solution in Open Angle Glaucoma or Ocular Hypertension (NCT03284853) | Aerie Pharmaceuticals | 2017-09-05 |
| Study of SHP639 Eye Drops in Adults With High Eye Pressure or Primary Open-angle Glaucoma (NCT03131167) | Shire | 2017-05-10 |
| Assessing Ocular Hemodynamic Response to Surgical Intervention in Glaucoma (NCT02891317) | University of North Carolina, Chapel Hill | 2017-05-08 |
| Exploratory Trial to Evaluate the Efficacy and Safety of D565H Twice Daily Versus D565 Once Daily (NCT03067415) | Chong Kun Dang Pharmaceutical | 2017-03-30 |
| Efficacy and Safety of ab Interno Trabeculectomy With the Kahook Dual Blade (NCT04202562) | Hospital San Carlos, Madrid | 2017-02-02 |
| Clinical Evaluation of CATS Tonometer Prism (NCT02989909) | Intuor Technologies, Inc. | 2017-01-01 |
| KJ-TFC-004 Drug-drug Interaction Study (NCT02967614) | Kukje Pharma | 2016-12-01 |
| Advanced Glycation End Products as a Biomarker for Accelerated Ageing (NCT02863224) | University of Plymouth | 2016-08-01 |
| Aqueous Dynamics and Glaucoma Surgeries (NCT02839590) | Guy's and St Thomas' NHS Foundation Trust | 2016-07-01 |
| Evaluation of Safety and Efficacy of TUG (Therapeutic Ultrasound for Glaucoma) in the Treatment of Primary Open Angle Glaucoma or Ocular Hypertension (NCT02858284) | EyeSonix | 2016-07-01 |
| Generic Travoprost Versus Brand Name Travoprost in Patients With Primary Open Angle Glaucoma or Ocular Hypertension (NCT02796560) | Université de Sherbrooke | 2016-07-01 |
| Safety and Efficacy of SIMBRINZA® BID as an Adjunctive to DUOTRAV® (NCT02730871) | Alcon Research | 2016-06-24 |
| Brinzolamide/Brimonidine Combination vs Brimonidine 0.2% in the Prevention of IOP Rise After Nd-YAG Laser Capsulotomy (NCT03192826) | University Hospital of Patras | 2016-06-20 |
| A Study on the Effect of Changing From Preserved Prostaglandin Formulations to Preservative Free Tafluprost on Tear Film Thickness (NCT03204487) | Ordination Dr. Hommer | 2016-05-10 |
| A Study to Evaluate Efficacy and Safety of a Fixed Combination Ocular Insert in Participants With Open-angle Glaucoma or Ocular Hypertension (NCT02742649) | ForSight Vision5, Inc. | 2016-04-30 |
| A Multi-center, Randomized, Blinded Evaluator, Active Control, Parallel, Phase III Study to Evaluate the Efficacy and Safety of TJO-002 in POAG or Ocular Hypertension Patients (NCT03419975) | Taejoon Pharmaceutical Co., Ltd. | 2016-04-26 |
| Non-inferiority of PRO-122 Ophthalmic Solution vs KRYTANTEK Ofteno® in Glaucoma or Ocular Hypertension (CONFORTK) (NCT03257813) | Laboratorios Sophia S.A de C.V. | 2016-04-01 |
| A Three Part Study of MGV354 in Ocular Hypertension or Glaucoma (NCT02743780) | Alcon Research | 2016-03-02 |
| SD-OCT Multimodal Analysis in GLaucoma (NCT02710916) | University Hospital, Bordeaux | 2016-02-22 |
| Double-masked Study of PG324 Ophthalmic Solution in Patients With Open-angle Glaucoma or Ocular Hypertension (NCT02674854) | Aerie Pharmaceuticals | 2016-02-01 |
| Surgical and Refractive Outcomes of Combined Glaucoma Surgery (NCT04335825) | Medical University of Bialystok | 2016-01-01 |
| A Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension -AYAME Study- (NCT02623738) | Santen Pharmaceutical Co., Ltd. | 2015-12-06 |
| Safety of GANFORT® Ophthalmic Solution in Chinese Patients With Open-angle Glaucoma or Ocular Hypertension (NCT02571712) | Allergan | 2015-11-10 |
| Assessment of Optic Nerve Radiation in Patients With Glaucoma and Ocular Hypertension by 7 Tesla Diffusion Tensor Imaging (NCT01864317) | Medical University of Vienna | 2015-11-01 |
| Double-masked Study of PG324 Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension (NCT02558400) | Aerie Pharmaceuticals | 2015-09-18 |
| Latanoprost Preserved Versus Unpreserved: Effect on Tear Film Thickness as Measured With OCT (NCT02585375) | Medical University of Vienna | 2015-09-17 |
| Double-masked Study of Netarsudil (AR-13324) Ophthalmic Solution in Subjects With Glaucoma or Ocular Hypertension (NCT02558374) | Aerie Pharmaceuticals | 2015-09-01 |
| A Comparison of Xalatan (Latanoprost) to Apo-latanoprost and Co-latanoprost in the Treatment of Glaucoma (NCT02792803) | Dr. David Yan | 2015-09-01 |